| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,477 |
40,779 |
$1.96M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,757 |
24,863 |
$1.72M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12,690 |
12,162 |
$835K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,180 |
10,148 |
$675K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
26,563 |
26,169 |
$516K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,476 |
6,457 |
$431K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
42,751 |
41,907 |
$402K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
29,703 |
25,182 |
$264K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,000 |
1,978 |
$165K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,110 |
2,101 |
$160K |
| 99051 |
|
9,267 |
9,133 |
$127K |
| 87634 |
|
2,000 |
1,978 |
$123K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,927 |
1,906 |
$121K |
| 90461 |
|
15,449 |
15,387 |
$118K |
| 87430 |
|
6,522 |
6,414 |
$85K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,970 |
3,037 |
$73K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,927 |
1,906 |
$47K |
| 99188 |
|
1,705 |
1,702 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,405 |
1,388 |
$43K |
| 94760 |
|
20,571 |
19,465 |
$42K |
| 83655 |
|
3,069 |
3,060 |
$34K |
| 96127 |
|
9,858 |
9,487 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,876 |
1,873 |
$31K |
| T1015 |
Clinic visit/encounter, all-inclusive |
140 |
138 |
$23K |
| 99401 |
|
311 |
309 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
153 |
153 |
$6K |
| 85018 |
|
2,738 |
2,728 |
$6K |
| 85014 |
|
2,348 |
2,341 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
156 |
151 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
156 |
151 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
80 |
80 |
$4K |
| G0299 |
Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes |
65 |
39 |
$4K |
| 99460 |
|
31 |
31 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
490 |
484 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
86 |
75 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
45 |
45 |
$3K |
| 0072A |
|
62 |
62 |
$3K |
| 0071A |
|
53 |
53 |
$2K |
| 85046 |
|
467 |
463 |
$2K |
| 99215 |
Prolong outpt/office vis |
17 |
17 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
12 |
$584.92 |
| 96161 |
|
3,268 |
3,179 |
$465.69 |
| 99173 |
|
25 |
25 |
$414.12 |
| 99441 |
|
30 |
30 |
$275.42 |
| 99442 |
|
15 |
15 |
$265.35 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
515 |
500 |
$201.25 |
| 96160 |
|
22,058 |
21,699 |
$195.48 |
| 90651 |
|
80 |
80 |
$173.11 |
| 90686 |
|
10,038 |
10,004 |
$140.08 |
| 81002 |
|
52 |
50 |
$139.32 |
| 83718 |
|
12 |
12 |
$101.40 |
| 85027 |
|
14 |
14 |
$79.94 |
| 82465 |
|
12 |
12 |
$53.76 |
| 90688 |
|
56 |
56 |
$37.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$1.20 |
| G9920 |
Screening performed and negative |
911 |
902 |
$0.00 |
| 99072 |
|
38,179 |
35,992 |
$0.00 |
| 90648 |
|
946 |
946 |
$0.00 |
| 90670 |
|
5,957 |
5,947 |
$0.00 |
| 90710 |
|
24 |
24 |
$0.00 |
| 90633 |
|
1,048 |
1,048 |
$0.00 |
| 90671 |
|
91 |
91 |
$0.00 |
| 90685 |
|
454 |
453 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
13 |
13 |
$0.00 |
| 90734 |
|
38 |
38 |
$0.00 |
| 90707 |
|
13 |
13 |
$0.00 |
| 90698 |
|
1,514 |
1,514 |
$0.00 |
| 90680 |
|
3,341 |
3,335 |
$0.00 |
| 91307 |
|
175 |
175 |
$0.00 |
| 90723 |
|
914 |
914 |
$0.00 |
| 36416 |
|
5,333 |
5,300 |
$0.00 |
| 90677 |
|
883 |
872 |
$0.00 |
| 90697 |
|
305 |
302 |
$0.00 |
| 90744 |
|
113 |
113 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15 |
15 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
14 |
14 |
$0.00 |
| 90716 |
|
24 |
24 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |